Aurobindo: US Tariffs “Not A Challenge” For Now, Scouting For Biosimilars Tie-Ups

“Entire” GLP-1 Range Including Semaglutide To Be Launched

US Tariffs Are Leading To Fears Of Business Disruption
US Tariffs Are Leading To Fears Of Business Disruption (Shutterstock)

More from India

More from R&D